Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01075412Phase 2Terminated
A Phase 2 trial of fluorothymidine F-18 in cervical squamous cell carcinoma (CSCC), sponsored by University of Iowa. Started Sep 2009; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01075412.